KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Net Cash Flow: 2009-2024

Historic Net Cash Flow for Bausch Health Companies (BHC) over the last 16 years, with Dec 2024 value amounting to $275.0 million.

  • Bausch Health Companies' Net Cash Flow fell 448.25% to -$397.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $571.0 million, marking a year-over-year increase of 1289.58%. This contributed to the annual value of $275.0 million for FY2024, which is 24.03% down from last year.
  • As of FY2024, Bausch Health Companies' Net Cash Flow stood at $275.0 million, which was down 24.03% from $362.0 million recorded in FY2023.
  • Bausch Health Companies' 5-year Net Cash Flow high stood at $362.0 million for FY2023, and its period low was -$1.5 billion during FY2022.
  • In the last 3 years, Bausch Health Companies' Net Cash Flow had a median value of $275.0 million in 2024 and averaged -$289.3 million.
  • Its Net Cash Flow has fluctuated over the past 5 years, first tumbled by 567.39% in 2022, then soared by 124.05% in 2023.
  • Yearly analysis of 5 years shows Bausch Health Companies' Net Cash Flow stood at -$1.4 billion in 2020, then skyrocketed by 122.30% to $322.0 million in 2021, then tumbled by 567.39% to -$1.5 billion in 2022, then spiked by 124.05% to $362.0 million in 2023, then dropped by 24.03% to $275.0 million in 2024.